Etzer Darout analyst BMO

Currently out of the existing stock ratings of Etzer Darout, 55 are a BUY (67.9%), 26 are a HOLD (32.1%).

Etzer Darout

Work Performance Price Targets & Ratings Chart

Analyst Etzer Darout works at BMO with a stock forecast success ratio of 45.15% fulfilled within 108.05 days on average.

Etzer Darout’s has documented 155 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on FATE, Fate Therapeutics at 10-May-2024.

Wall Street Analyst Etzer Darout

Analyst best performing recommendations are on FPRX (FIVE PRIME THERAPEUTICS).
The best stock recommendation documented was for MGNX (MACROGENICS) at 7/11/2022. The price target of $4 was fulfilled within 2 days with a profit of $0.45 (12.68%) receiving and performance score of 63.38.

Average potential price target upside

DMAC DiaMedica Therapeutics MGNX MacroGenics MIRM Mirum Pharmaceuticals VERV Verve Therapeutics CTMX CytomX Therapeutics EXEL Exelixis FATE Fate Therapeutics GMAB Genmab AS IMGN ImmunoGen MRUS Merus BV SGEN Seagen NUVL Nuvalent XNCR Xencor FPRX Five Prime Therapeutics ALNY Alnylam Pharmaceuticals YMAB Y mAbs Therapeutics ARVN Arvinas FTSV Forty Seven AZN AstraZeneca PLC ADR CCCC C4 Therapeutics  IVA Inventiva Sa

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

8

$5.12 (177.78%)

11

1 months 2 days ago

1/5 (20%)

$5.55 (226.53%)

720

Buy

7

$4.12 (143.06%)

11 months 4 days ago

0/2 (0%)

$2.95 (72.84%)

Hold

1 years 10 months 19 days ago

0/2 (0%)

$17.96 (178.88%)

Buy

11

$8.42 (326.36%)

14

2 years 10 months 26 days ago

0/2 (0%)

$6.82 (124.75%)

Buy

38

2 years 10 months 27 days ago

0/1 (0%)

$27.58 (264.68%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Etzer Darout is most bullish on?

Potential upside of $54.77 has been obtained for ARVN (ARVINAS)

Which stock is Etzer Darout is most reserved on?

Potential downside of -$1.99 has been obtained for MRUS (MERUS BV)

What Year was the first public recommendation made by Etzer Darout?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?